0000874015-22-000137.txt : 20220719
0000874015-22-000137.hdr.sgml : 20220719
20220719192017
ACCESSION NUMBER: 0000874015-22-000137
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220715
FILED AS OF DATE: 20220719
DATE AS OF CHANGE: 20220719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Diaz Allene M.
CENTRAL INDEX KEY: 0001773314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 221092525
MAIL ADDRESS:
STREET 1: C/O ALLENA PHARMACEUTIALS, INC.
STREET 2: ONEW NEWTON EXECUTIVE PARK SUITE 202
CITY: NEWTON
STATE: MA
ZIP: 02462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-07-15
0
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001773314
Diaz Allene M.
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
0
0
0
Common Stock
2022-07-15
4
M
0
8000
0.0
A
8000
D
Restricted Stock Unit
0.0
2022-07-15
4
M
0
8000
0.0
D
Common Stock
8000
5333
D
Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
By: Patrick R. O'Neil, attorney-in-fact For: Allene M. Diaz
2022-07-18